ArticleGenome medicine2026
African ancestry-enriched variants in the GATM gene are associated with elevated serum creatinine levels.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TLS-Tractor: A transfer learning framework for incorporating summary-statistics into local ancestry-aware GWAS in admixed populations.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
backgroundSerum creatinine (Scr) levels are routinely used to estimate kidney function and health. Individuals of African ancestry have higher Scr levels – controlling for differences in age, sex, size, kidney function, and disease status – compared to individuals from other ancestral backgrounds. The reason for this difference is unknown. We hypothesized that there may be genetic variants found at relatively high frequency in African ancestry groups (African ancestry-enriched variants) that are associated with elevated Scr levels African ancestry individuals.
methodsOur study sample is made up of participants from the All of Us Research Program. We used whole genome sequence data to estimate genetic ancestry for All of Us participants and selected a cohort of 18,979 participants with two way African-European admixture, available Scr level measures, and demographic covariables. We performed a series of ancestry-informed association studies of Scr levels on this cohort to test our hypothesis of African ancestry-enriched variants associated with Scr.
resultsStudy participants show an average of 80.8% African and 17.5% European ancestry. Participant Scr levels are positively correlated with African ancestry for females (𝜌=0.79) and males (𝜌=0.84). The same peak of genome-wide significant associations was identified on chromosome 15 (15q23:45.3 Mb-45.5 Mb) using standard GWAS, haplotype-based admixture mapping, and ancestry-specific GWAS. The alternate allele for the lead GWAS variant (rs2467850, chr15:45379909:C: T) is positively associated with Scr levels (β = 0.07, p = 2.28 × 10−17) and found at higher frequency in African (0.413) compared to European ancestry (0.001) groups. Fine mapping identified a credible set of 14 variants co-located with the GATM gene, which encodes a biosynthetic enzyme for creatine, a metabolic precursor of creatinine. 13 of these variants are positively associated with GATM expression, based on a previous study of whole blood eQTL in African Americans, and they all show similar patterns of African ancestry-enrichment. An Scr GWAS association score based on 10 African ancestry-enriched variants completely attenuates the observed association of African ancestry with Scr levels.
conclusionsOur findings indicate that African ancestry-enriched variants up-regulate GATM, thereby explaining the higher levels of Scr observed in individuals of African ancestry, and underscore the potential for using genetic data to better calibrate kidney function equations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.